Free Trial

Severfield (SFR) Competitors

Severfield logo
GBX 87.06 -0.94 (-1.06%)
(As of 08:23 AM ET)

SFR vs. TRX, NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, and WPM

Should you be buying Severfield stock or one of its competitors? The main competitors of Severfield include Tissue Regenix Group (TRX), Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), and Wheaton Precious Metals (WPM). These companies are all part of the "precious metals" industry.

Severfield vs.

Severfield (LON:SFR) and Tissue Regenix Group (LON:TRX) are both small-cap industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, community ranking, risk, institutional ownership and media sentiment.

Severfield received 64 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 76.09% of users gave Severfield an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote.

CompanyUnderperformOutperform
SeverfieldOutperform Votes
226
76.09%
Underperform Votes
71
23.91%
Tissue Regenix GroupOutperform Votes
162
69.53%
Underperform Votes
71
30.47%

Severfield has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Comparatively, Tissue Regenix Group has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500.

In the previous week, Severfield had 1 more articles in the media than Tissue Regenix Group. MarketBeat recorded 1 mentions for Severfield and 0 mentions for Tissue Regenix Group. Severfield's average media sentiment score of 1.05 beat Tissue Regenix Group's score of 0.00 indicating that Severfield is being referred to more favorably in the media.

Company Overall Sentiment
Severfield Positive
Tissue Regenix Group Neutral

66.9% of Severfield shares are owned by institutional investors. Comparatively, 37.0% of Tissue Regenix Group shares are owned by institutional investors. 4.4% of Severfield shares are owned by company insiders. Comparatively, 47.3% of Tissue Regenix Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Severfield has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Severfield, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Severfield£463.46M0.56£15.90M£0.051,736.00
Tissue Regenix Group£31.80M1.30-£1.10M-£0.01-5,800.00

Severfield has a net margin of 3.43% compared to Tissue Regenix Group's net margin of -3.46%. Severfield's return on equity of 7.25% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Severfield3.43% 7.25% 4.69%
Tissue Regenix Group -3.46%-3.31%0.50%

Summary

Severfield beats Tissue Regenix Group on 12 of the 15 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SFR vs. The Competition

MetricSeverfieldEngineering & Construction IndustryIndustrials SectorLON Exchange
Market Cap£260.77M£1.79B£3.89B£1.38B
Dividend Yield4.64%3.73%4.41%11.73%
P/E Ratio1,736.00383.23530.611,551.40
Price / Sales0.5644.84428.09212,370.00
Price / Cash16.9413.6227.7932.93
Price / Book1.222.363.572.80
Net Income£15.90M£69.93M£179.69M£152.70M
7 Day Performance-1.81%-0.06%3.38%-0.43%
1 Month Performance4.58%0.21%-1.32%7.18%
1 Year Performance33.54%71.47%28.91%91.53%

Severfield Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SFR
Severfield
N/AGBX 87.06
-1.1%
N/A+35.4%£261.57M£463.46M1,741.281,900Dividend Cut
Positive News
Gap Down
TRX
Tissue Regenix Group
N/AGBX 58
-1.7%
N/A+4.7%£41.31M£31.80M-5,926.70120
NAK
Nakama Group plc (NAK.L)
N/AGBX 1.23
+6.5%
N/A+0.0%£1.44M£8.09M-6.1353Gap Down
High Trading Volume
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/A0.006Gap Down
High Trading Volume
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/A0.005,360High Trading Volume
EDG
651814 (EDG.L)
N/AN/AN/AN/A£0.00N/A0.002,610
MTA
ArcelorMittal
N/AN/AN/AN/A£0.00N/A0.009High Trading Volume
NGR
Nature Group
N/AN/AN/AN/A£0.00N/A0.0010Gap Up
RRS
Randgold Resources
N/AGBX 6,546
+7,701,076.5%
N/AN/A£0.00N/A0.0021,300Gap Up
NG
National Grid
1.3356 of 5 stars
GBX 982.60
-0.5%
GBX 1,181.25
+20.2%
-2.8%£48.05B£19.85B1,796.0010High Trading Volume
WPM
Wheaton Precious Metals
0.7818 of 5 stars
GBX 4,901.80
-0.4%
GBX 5,200
+6.1%
+36.2%£22.24B£1.13B5,106.0442Positive News

Related Companies and Tools


This page (LON:SFR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners